首页> 外文期刊>Hepatitis Monthly >HCV Infection among Injecting Drug Users in Prishtina, Kosovo
【24h】

HCV Infection among Injecting Drug Users in Prishtina, Kosovo

机译:科索沃普里什蒂纳注射毒品使用者中的HCV感染

获取原文
           

摘要

Background: Globally, 10 million injecting drug users (IDUs) are estimated to be HCV-positive, resulting in a prevalence of 67%. We evaluated the previously unassessed HCV infection amongst IDUs in Kosovo. We determined the distribution of HCV genotypes among IDUs in Prishtina, ascertained their phylogenetic relatedness, and investigated the main risk factors associated with the HCV infection. Methods: Samples were obtained from 205 IDUs in Prishtina, Kosovo, during the Biological and Behavioral Surveillance Study (BioBSS). HCV-positive samples were further genotyped and sequenced. The results were linked with epidemiological data obtained in interviews determining the underlying causes of HCV transmission. Results: The majority of the 205 IDUs participating in the BioBSS were men (89.3%) with a mean age of 36 years and a history of imprisonment, unemployment, and over a decade of injection drug use. Forty-eight percent of the IDUs were positive for anti-HCV antibodies, and HCV RNA was detected in 70 IDUs (70.7% of the anti-HCV positive IDUs). The following HCV subtypes were detected: subtype 1a (64.3%), subtype 3a (34.3%), and subtype 2k (1.4%). Phylogenetic clustering was evident among 66.7% of the HCV subtype 1a samples and 71.4% of the subtype 3a samples. Significant independent predictors for anti-HCV positivity among IDUs were older age, longer duration of drug use, low education level, drug injection in “shooting galleries”, and imprisonment. Conclusions: In Prishtina, Kosovo, nearly half of the IDUs were determined to be anti-HCV positive and the majority had an active infection. HCV subtype 1a was found to be most prevalent, followed by subtype 3a. Our results emphasize the urgent need for the implementation of harm-reduction programs among IDUs in Kosovo, specifically treatment and prevention through needle/syringe exchange programs directed at gathering places, such as shooting galleries.
机译:背景:全球估计有1000万注射吸毒者(HCV)阳性,导致67%的患病率。我们评估了科索沃注射毒品者中先前未评估的HCV感染。我们确定了普里什蒂纳地区IDU中HCV基因型的分布,确定了它们的系统发育相关性,并调查了与HCV感染相关的主要危险因素。方法:在生物和行为监测研究(BioBSS)期间,从科索沃Prishtina的205个IDU中获取了样本。 HCV阳性样品进一步进行基因分型和测序。该结果与通过访谈确定HCV传播潜在原因的流行病学数据相关。结果:参加BioBSS的205个注射毒品使用者中,大多数是男性(89.3%),平均年龄为36岁,有监禁,失业和使用注射毒品超过十年的历史。 IDU中有48%的抗HCV抗体呈阳性,并且在70个IDU中检测到HCV RNA(占抗HCV阳性IDU的70.7%)。检测到以下HCV亚型:亚型1a(64.3%),亚型3a(34.3%)和2k亚型(1.4%)。系统发育聚类在HCV 1a亚型样本中占66.7%,在3a亚型样本中占71.4%。注射毒品使用者中抗HCV阳性的重要独立预测因素是年龄大,吸毒时间长,受教育程度低,在“射击场”注射毒品和入狱。结论:在科索沃的普里什蒂纳,确定将近一半的注射吸毒者为抗丙型肝炎病毒阳性,并且大多数感染者是活动性感染。发现HCV 1a亚型最为普遍,其次是3a亚型。我们的结果强调,迫切需要在科索沃的注射毒品使用者之间实施减少伤害的计划,特别是通过针对集会场所(如射击场)的针头/注射器互换计划进行治疗和预防。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号